Improving Concordance Between Clinicians With Australian Guidelines for Bowel Cancer Prevention Using a Digital Application: Randomized Controlled Crossover Study.
Tsai-Wing OwOlga A SukochevaPeter BamptonGuruparan IyngkaranChristopher K RaynerEdmund TsePublished in: JMIR cancer (2024)
DAs can significantly improve the adoption of complex Australian bowel cancer prevention guidelines. As screening and surveillance guidelines become increasingly complex and personalized, these tools will be crucial to help clinicians accurately determine the most appropriate recommendations for their patients. Additional research to understand why some practitioners perform worse with DAs is required. Further improvements in application usability may optimize guideline concordance further.
Keyphrases
- clinical practice
- papillary thyroid
- end stage renal disease
- squamous cell
- ejection fraction
- palliative care
- newly diagnosed
- chronic kidney disease
- primary care
- disease activity
- electronic health record
- open label
- peritoneal dialysis
- double blind
- lymph node metastasis
- healthcare
- clinical trial
- randomized controlled trial
- squamous cell carcinoma
- systemic lupus erythematosus
- phase iii
- placebo controlled
- general practice
- health information
- phase ii